Furthermore, Cheng et al. demonstrated in an in vitro study using the T98G human GBM cell line that the transcription factor SREBP2 (sterol regulatory element-binding protein-2), known for promoting de novo cholesterol synthesis, also regulated GLUT1 expression. Here, SLC2A1 is linked to glioblastoma.